Professor Wendy Hoy FRACP | |
---|---|
Born | Wendy Elizabeth Hoy |
Alma mater | University of Sydney Royal Australasian College of Physicians (PhD) |
Professor Wendy Elizabeth Hoy AO is a Fellow of the Australian Academy of Science (FAA), the Director of the Centre for Chronic Disease at the University of Queensland, Australia, and was appointed an Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Science in 2015. Hoy's research has involved developing new types of kidney imaging and improving health and lives for indigenous populations, in Australia, Sri Lanka and the USA. [1] [2]
Hoy attended Telopea Park High School, Canberra in Australia, and came first in the Australian Capital Territory, for two subjects, and second in the school. [3] She was awarded first class honours in Immunology (BScMed) and in Medicine and Surgery at the University of Sydney. After twenty years working the US, Hoy subsequently returned to Australia. [4]
Hoy specialises in cross-disciplinary research in indigenous health services, as well as kidney and related chronic diseases, and health system modelling. Colleagues have described her work as "transforming the Australian Indigenous Aboriginal health services, as well as decreasing the need for dialysis and developing early interventions across the planet". [5] Hoy's career has changed mortality and related issues within regional Aboriginal communities over the last five decades. Hoy's research also involves measuring how prematurity and low birth weight can influence adult health. Additionally, her research involves factors that lead to kidney disease within African-Americans and Aborigines. [6]
Hoy's work has focused on chronic conditions, including chronic kidney disease in the Indigenous population in Australia, and related diseases. [7] Hoy said "kidney disease was a huge and growing issue in the indigenous community and across the wider population". [8] [9]
Hoy studied three Indigenous and remote communities of Indigenous Australians, and reported that "as people aged the prevalence of chronic conditions including hypertension, renal failure, diabetes and cardiovascular disease also increases". [10] Across her career, Hoy's work has substantially reduced the suffering and improved health outcomes of Indigenous Australians with kidney disease. [11] [12] In addition to working with Indigenous Australian communities, Hoy also has consulted with Sri Lanka and Central American on Chronic Kidney Disease. [13]
As at August 2019, Hoy had over 300 peer-reviewed manuscripts, an H number of 56 and over 13,000 citations. [14]
Kidney dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy. The first successful dialysis was performed in 1943.
The UQ Law School is the law school of the University of Queensland in Brisbane, Australia. Founded in 1936, UQ law school is the sixth oldest law school in Australia and the oldest operating in Queensland.
The University of Queensland Library provides library access to students of the University of Queensland in Brisbane. It developed from a small provincial university library into a major research library. It was first housed in the Old Government House building of George Street from 1911 to 1923. From 1923 to 1948, it was housed in the Art Block of the Central Technical College in George Street, next to the university. In late 1948, the library moved to the new St Lucia campus, residing in the Duhig Building. By 1954, it had already exceeded its capacity.
Indigenous health in Australia examines health and wellbeing indicators of Indigenous Australians compared with the rest of the population. Statistics indicate that Aboriginal Australians and Torres Strait Islanders are much less healthy than other Australians. Various government strategies have been put into place to try to remediate the problem; there has been some improvement in several areas, but statistics between Indigenous Australians and the rest of the Australian population still show unacceptable levels of difference.
Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.
Jennifer Lea Stow is deputy director (research), NHMRC Principal Research Fellow and head of the Protein Trafficking and Inflammation laboratory at the Institute for Molecular Bioscience (IMB), The University of Queensland, Australia. She received a PhD from Monash University in Melbourne in 1982., postdoctoral training at Yale University School of Medicine (US) in the Department of Cell Biologyand first faculty position as an assistant professor at Harvard University in the Renal Unit, Departments of Medicine and Pathology at the Massachusetts General Hospital in Boston.
Glenda Gobe is a molecular biologist specialising in the molecular controls of apoptosis in kidney disease. She is Co-Director of the Centre for Kidney Disease Research (CKDR), School of Medicine, Translational Research Institute and The University of Queensland and Reader in the Discipline of Medicine at the School of Medicine, University of Queensland.
The Translational Research Institute (TRI) is Australia's first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.
Diabetes, in particular, non-insulin-dependent diabetes, is prevalent in the Aboriginal and Torres Strait Islander populations of Australia. As many as 1 in 20 Australians are said to suffer from diabetes. Aboriginal people are three times as likely to become diabetic in comparison to non-Aboriginal people. In contrast with type 1 diabetes, which is a predisposed autoimmune condition, type 2 diabetes or insulin-resistant diabetes, is a preventable disease, heavily influenced by a multitude of socioeconomic factors. Sufferers of the disease are consequently more susceptible to chronic health issues, including heart disease and kidney failure. Conclusively, this has contributed to the 17 year life expectancy gap between Aboriginal people and non-Aboriginal people and has led to health inequities between Aboriginal people and non-Aboriginal people.
Mark A. F. Kendall is an Australian biomedical engineer, inventor, scientist and entrepreneur.
Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.
Felicity Meakins is a linguist specialising in Australian Indigenous languages, morphology and language contact, who was one of the first academics to describe Gurindji Kriol. As of 2022, she is a professor at the University of Queensland and Deputy Director of the University of Queensland node of the Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language. She holds an ARC Future Fellowship focusing on language evolution and contact processes across northern Australia.
Professor David Wayne Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.
Melissa Helen Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.
Lianzhou Wang is a Chinese Australian materials scientist and professor in the School of Chemical Engineering at the University of Queensland. He is director of the Nanomaterials Centre (Nanomac) and a senior group member at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland, as well as a Fellow of the Royal Society of Chemistry.
Jaquelyne Hughes FRACP is a Torres Strait Islander woman and senior research fellow at Menzies School of Health Research, Charles Darwin University. She also works as a nephrologist at the Royal Darwin Hospital.
Karen H. Black, born about 1970, is a palaeontologist at the University of New South Wales. Black is the leading author on research describing new families, genera and species of fossil mammals. She is interested in understanding faunal change and community structure in order to gain new understandings of past, current and future changes in biodiversity which are driven by climate.
Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital, serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.
Helen Margaret Stallman is an Australian scientist, clinical psychologist and author. She is director of the International Association of University Health and Wellbeing.
Bronwyn Fredericks is an Indigenous Australian academic and administrator. Her scholarship extends across education, health, community development, policy, and Indigenist research methods, including a focus on work relevant to Aboriginal and Torres Strait Islander people using participatory and community led approaches. Her contributions have been recognised through the NAIDOC Education Award in 2022 and the Aboriginal and Torres Strait Islander Health Award in 2019. She is currently the Deputy Vice Chancellor at the University of Queensland.
{{cite web}}
: CS1 maint: numeric names: authors list (link){{cite web}}
: CS1 maint: numeric names: authors list (link)